Skip to main content
Clinical Trials/TCTR20220117005
TCTR20220117005RecruitingPhase 4

Incidence of hypertensive response during endotracheal intubation between supplement intravenous bolus propofol and sevoflurane: A prospective randomized-controlled trial

Faculty of Medicine, Khon Kaen University0 sites66 target enrollmentStarted: January 17, 2022Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Enrollment
66

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 65 Years (—)
Sex
All

Inclusion Criteria

  • Adult 18-65 years
  • ASA physical status I-II

Exclusion Criteria

  • SBP baseline < 100 mmHg and/or HR < 50 bpm.
  • BMI > 30kg/m2
  • Anticipated difficult intubation
  • Risk aspiration
  • Patients with severe cardiovascular diseases
  • Contraindication for propofol, fentanyl, cisatracurium and sevoflurence
  • Abnormal EKG: bradycardia < 50 bpm, second to third degree AV block, LBBB, ST-T change that indicate MI

Investigators

Similar Trials